Also, due to the established anti‐inflammatory aspect, serum CTRP9, by diminishing inflammatory indicators as well as adjusting lipid profile, is implicated as a promising factor in terms of coronary atherosclerosis treatment in clinical practice.23 The gene discussed is C1QTNF9; the disease is coronary atherosclerosis.